Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is … Read More
The post Therapix Signs Formulation Development and Clinical Manufacturing Agreement with Catalent for … appeared first on Dagga Magazine.